These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 20579720)

  • 21. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.
    Ortqvist A; Berggren I; Insulander M; de Jong B; Svenungsson B
    Clin Infect Dis; 2011 May; 52(10):1203-11. PubMed ID: 21507917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination.
    Vesikari T; Groth N; Karvonen A; Borkowski A; Pellegrini M
    Vaccine; 2009 Oct; 27(45):6291-5. PubMed ID: 19840662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant.
    Vesikari T; Pellegrini M; Karvonen A; Groth N; Borkowski A; O'Hagan DT; Podda A
    Pediatr Infect Dis J; 2009 Jul; 28(7):563-71. PubMed ID: 19561422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.
    Ortqvist A; Bennet R; Rinder MR; Lindblad H; Eriksson M
    Vaccine; 2012 Aug; 30(39):5699-702. PubMed ID: 22819987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.
    Song JY; Cheong HJ; Heo JY; Noh JY; Choi WS; Park DW; Lee J; Jeong HW; Kee SY; Kim WJ
    Vaccine; 2011 Feb; 29(7):1395-8. PubMed ID: 21199701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaphylaxis following H1N1 pandemic vaccines: safety data in perspective.
    Tavares F; Delaigle A; Slavin D; Bauchau V; Fries L; Seifert H
    Vaccine; 2011 Aug; 29(37):6402-7. PubMed ID: 21527305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study.
    Stowe J; Andrews N; Bryan P; Seabroke S; Miller E
    Vaccine; 2011 Nov; 29(51):9467-72. PubMed ID: 22019757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.
    Choe YJ; Cho H; Song KM; Kim JH; Han OP; Kwon YH; Bae GR; Lee HJ; Lee JK
    Jpn J Infect Dis; 2011; 64(4):297-303. PubMed ID: 21788704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of live attenuated influenza vaccine in atopic children with egg allergy.
    Turner PJ; Southern J; Andrews NJ; Miller E; Erlewyn-Lajeunesse M;
    J Allergy Clin Immunol; 2015 Aug; 136(2):376-81. PubMed ID: 25684279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.
    Gilca R; Deceuninck G; De Serres G; Boulianne N; Sauvageau C; Quach C; Boucher FD; Skowronski DM
    Pediatrics; 2011 Nov; 128(5):e1084-91. PubMed ID: 21987710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
    Roman F; Vaman T; Gerlach B; Markendorf A; Gillard P; Devaster JM
    Vaccine; 2010 Feb; 28(7):1740-5. PubMed ID: 20034605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergy.
    Greenhawt MJ; Spergel JM; Rank MA; Green TD; Mansoor D; Sharma H; Bird JA; Chang JE; Parikh DS; Teich E; Kelso JM; Sanders GM
    Ann Allergy Asthma Immunol; 2012 Dec; 109(6):426-30. PubMed ID: 23176882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.
    Levie K; Leroux-Roels I; Hoppenbrouwers K; Kervyn AD; Vandermeulen C; Forgus S; Leroux-Roels G; Pichon S; Kusters I
    J Infect Dis; 2008 Sep; 198(5):642-9. PubMed ID: 18576945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Egg allergy and vaccine against the new influenza. A plan of action in Ostergotland].
    Kronander UN; Nilsson L
    Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3230. PubMed ID: 20101832
    [No Abstract]   [Full Text] [Related]  

  • 39. Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients.
    Altamirano-Diaz L; West L; Humar A; Ely L; Urschel S; Gubbay J; Crowcroft N; Kumar D
    Pediatr Transplant; 2011 Mar; 15(2):172-5. PubMed ID: 21176017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J; Fang HH; Chen JT; Zhou JC; Feng ZJ; Li CG; Qiu YZ; Liu Y; Lu M; Liu LY; Dong SS; Gao Q; Zhang XM; Wang N; Yin WD; Dong XP
    Clin Infect Dis; 2009 Apr; 48(8):1087-95. PubMed ID: 19281330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.